{"presentation":{"slides":[{"elements":[{"x":5.446623093681917,"y":6.491490280777537,"width":89.32461873638344,"height":45.35637149028078,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

All clinically suspecious cutaneous TB lesions should be treated for cutaneous TB:<\/span><\/strong><\/p>\n\n

\n\t
\n\t
Patients with positive culture of Mtb or microscopy for AFBs from skin biopsy<\/p>\n\t<\/li>\n\t
\n\t
Patients with histology suggestive<\/strong> of cutaneous TB<\/p>\n\t<\/li>\n\t
\n\t
Suspicious skin lesion with equivocal histology findings, negative AFB and culture, strongly positive Mantoux test, Can be given ATT<\/strong><\/p>\n\t<\/li>\n<\/ul>\n"},"subContentId":"ee8cb58a-6068-4880-b738-52e40efd773a","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":43.57298474945534,"y":82.07343412526998,"width":55.33769063180828,"height":17.278617710583152,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"

\nIndex TB Guidelines, 2016<\/span><\/span><\/span><\/span><\/span>
\nM Ramam et al. appropriate duration of therapeutic trial in cutaneous TB, Indian J. of Dermatology 2007<\/span><\/span><\/span><\/p>\n"},"subContentId":"9d717357-a298-46be-a5a2-b8326d667a3e","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":39.21568627450981,"y":43.2866090712743,"width":49.01960784313726,"height":38.8768898488121,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"
\n\t
\n\t
Anti-tubercular therapy: 2HRZE + 4HRE<\/strong><\/p>\n\t<\/li>\n\t
\n\t
Duration- 6months<\/p>\n\t<\/li>\n\t
\n\t
Follow up to assess treatment response at 4-6weeks followed by 8 weekly intervals<\/p>\n\t<\/li>\n\t
\n\t
Sequelae- Scarring<\/p>\n\t<\/li>\n<\/ul>\n"},"subContentId":"69b9ceb5-4448-4505-b846-c1f5895d5455","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":18.51851851851852,"y":47.51619870410367,"width":17.429193899782135,"height":34.341252699784015,"action":{"library":"H5P.Image 1.1","params":{"decorative":false,"contentName":"Image","file":{"path":"images\/file-649569635150c.png","mime":"image\/png","copyright":{"license":"U"},"width":512,"height":512}},"subContentId":"70795b94-adbf-4c3a-baae-4d092fc92adb","metadata":{"contentType":"Image","license":"U","title":"Untitled Image"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""},{"x":6.5359477124183005,"y":88.55291576673866,"width":23.965141612200437,"height":10.799136069114471,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"
H= Isoniazid, R= Rifampin, Z= pyrazinamide, E= Ethambutol<\/span><\/span><\/span><\/span><\/span><\/p>\n"},"subContentId":"cbd3e905-0f73-4319-9a4f-6732e53cc776","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""}],"slideBackgroundSelector":{}},{"elements":[{"x":5.446623093681917,"y":6.491490280777537,"width":89.32461873638344,"height":64.79481641468682,"action":{"library":"H5P.AdvancedText 1.1","params":{"text":"
Summarizing the case approach<\/strong><\/span><\/p>\n\n
\n\t
\n\t
A high index of suspicion is needed <\/p>\n\t<\/li>\n\t
\n\t
Fever and other constitutional symptoms generally absent in isolated cutaneous TB<\/p>\n\t<\/li>\n\t
\n\t
Tissue sampling and histopathological examination is mainstay of diagnosis <\/p>\n\t<\/li>\n\t
\n\t
In scrofuloderma, FNA from underlying lymph node increases diagnostic yield<\/p>\n\t<\/li>\n\t
\n\t
A clinical response to multidrug therapy is usually evident within five-six weeks<\/p>\n\t<\/li>\n\t
\n\t
Re-evaluate diagnosis if patient fails to improve even after 6 weeks of ATT trial<\/p>\n\t<\/li>\n<\/ul>\n"},"subContentId":"64d502b5-6ffd-4ddd-a52d-15dd0e19a51d","metadata":{"contentType":"Text","license":"U","title":"Untitled Text"}},"alwaysDisplayComments":false,"backgroundOpacity":0,"displayAsButton":false,"buttonSize":"big","goToSlideType":"specified","invisible":false,"solution":""}],"slideBackgroundSelector":{}}],"keywordListEnabled":true,"globalBackgroundSelector":{},"keywordListAlwaysShow":false,"keywordListAutoHide":false,"keywordListOpacity":90},"override":{"activeSurface":false,"hideSummarySlide":false,"summarySlideSolutionButton":true,"summarySlideRetryButton":true,"enablePrintButton":false,"social":{"showFacebookShare":false,"facebookShare":{"url":"@currentpageurl","quote":"I scored @score out of @maxScore on a task at @currentpageurl."},"showTwitterShare":false,"twitterShare":{"statement":"I scored @score out of @maxScore on a task at @currentpageurl.","url":"@currentpageurl","hashtags":"h5p, course"},"showGoogleShare":false,"googleShareUrl":"@currentpageurl"}},"l10n":{"slide":"Slide","score":"Score","yourScore":"Your Score","maxScore":"Max Score","total":"Total","totalScore":"Total Score","showSolutions":"Show solutions","retry":"Retry","exportAnswers":"Export text","hideKeywords":"Hide sidebar navigation menu","showKeywords":"Show sidebar navigation menu","fullscreen":"Fullscreen","exitFullscreen":"Exit fullscreen","prevSlide":"Previous slide","nextSlide":"Next slide","currentSlide":"Current slide","lastSlide":"Last slide","solutionModeTitle":"Exit solution mode","solutionModeText":"Solution Mode","summaryMultipleTaskText":"Multiple tasks","scoreMessage":"You achieved:","shareFacebook":"Share on Facebook","shareTwitter":"Share on Twitter","shareGoogle":"Share on Google+","summary":"Summary","solutionsButtonTitle":"Show comments","printTitle":"Print","printIngress":"How would you like to print this presentation?","printAllSlides":"Print all slides","printCurrentSlide":"Print current slide","noTitle":"No title","accessibilitySlideNavigationExplanation":"Use left and right arrow to change slide in that direction whenever canvas is selected.","accessibilityCanvasLabel":"Presentation canvas. Use left and right arrow to move between slides.","accessibilityProgressBarLabel":"Choose slide to display","containsNotCompleted":"@slideName contains not completed interaction","containsCompleted":"@slideName contains completed interaction","slideCount":"Slide @index of @total","containsOnlyCorrect":"@slideName only has correct answers","containsIncorrectAnswers":"@slideName has incorrect answers","shareResult":"Share Result","accessibilityTotalScore":"You got @score of @maxScore points in total","accessibilityEnteredFullscreen":"Entered fullscreen","accessibilityExitedFullscreen":"Exited fullscreen","confirmDialogHeader":"Submit your answers","confirmDialogText":"This will submit your results, do you want to continue?","confirmDialogConfirmText":"Submit and see results","slideshowNavigationLabel":"Slideshow navigation"}}

Search

Management and follow-up of cutaneous TB

Content Status

Type

Linked Node

Management and follow-up of cutaneous TB

Content Creator

Reviewer